HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasunori Sato Selected Research

Atherosclerosis

1/2022Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall-a sub-analysis of the UTOPIA trial.
9/2021The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
1/2021Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
1/2020Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
10/2017Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
4/2017Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.
6/2016Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
6/2016The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.
1/2016Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.
6/2014Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasunori Sato Research Topics

Disease

70Neoplasms (Cancer)
06/2022 - 08/2002
39Cholangiocarcinoma
11/2022 - 11/2003
23Carcinoma (Carcinomatosis)
06/2022 - 04/2006
15Type 2 Diabetes Mellitus (MODY)
01/2022 - 09/2014
11Neoplasm Metastasis (Metastasis)
06/2021 - 12/2004
10Atherosclerosis
01/2022 - 06/2014
10Fibrosis (Cirrhosis)
01/2021 - 08/2005
10Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 02/2010
10Hepatocellular Carcinoma (Hepatoma)
09/2020 - 07/2009
10Carcinogenesis
06/2016 - 11/2007
9Adenocarcinoma
01/2020 - 04/2008
9Brain Neoplasms (Brain Tumor)
01/2020 - 12/2010
8Heart Failure
01/2022 - 01/2013
8Necrosis
11/2018 - 07/2002
7Carcinoma in Situ
06/2022 - 12/2004
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2016
7Body Weight (Weight, Body)
06/2021 - 04/2016
7Breast Neoplasms (Breast Cancer)
03/2020 - 01/2008
6Hepatitis
04/2014 - 07/2002
5Paralysis (Palsy)
01/2022 - 11/2018
5Diabetes Mellitus
12/2021 - 06/2014
5Lung Diseases (Lung Disease)
01/2021 - 09/2006
5Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2021 - 02/2004
5Cysts
01/2021 - 06/2006
5POEMS Syndrome (Syndrome, POEMS)
05/2020 - 01/2015
5Pancreatic Neoplasms (Pancreatic Cancer)
05/2018 - 08/2008
5Wounds and Injuries (Trauma)
02/2016 - 07/2002
5Sclerosing Cholangitis
06/2014 - 01/2010
4Hypoglycemia (Reactive Hypoglycemia)
02/2021 - 12/2012
4Immunoglobulin G4-Related Disease
01/2021 - 08/2007
4Infections
12/2019 - 10/2007
4Inflammation (Inflammations)
12/2018 - 07/2011
4Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
10/2017 - 02/2004
4Cholangitis
05/2014 - 06/2007
4Metaplasia
12/2012 - 06/2006
3Adenoma (Adenomas)
02/2022 - 03/2009
3Hypoxia (Hypoxemia)
01/2022 - 10/2007
3Hyperuricemia
01/2022 - 06/2016
3Obstructive Sleep Apnea
01/2022 - 01/2017
3Melanoma (Melanoma, Malignant)
12/2021 - 10/2007
3Insulin Resistance
12/2021 - 10/2014
3Caroli Disease (Caroli's Disease)
08/2021 - 02/2009
3Congenital Hepatic Fibrosis
08/2021 - 08/2005
3Stomach Neoplasms (Stomach Cancer)
07/2021 - 06/2008
3Gallbladder Neoplasms (Gallbladder Cancer)
06/2021 - 03/2012
3Schizophrenia (Dementia Praecox)
06/2021 - 01/2018
3Lymphatic Metastasis
06/2021 - 07/2018
3Coronary Artery Disease (Coronary Atherosclerosis)
02/2021 - 09/2016
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 10/2006

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2004
16Bile Pigments (Bilin)IBA
06/2022 - 11/2007
11Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2011
10MucinsIBA
09/2020 - 04/2008
8Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 01/2016
8Immunoglobulin G (IgG)IBA
01/2022 - 06/2005
8AntigensIBA
06/2021 - 06/2008
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 10/2007
7Sitagliptin Phosphate (Januvia)FDA Link
02/2021 - 12/2012
6Insulin (Novolin)FDA Link
12/2021 - 09/2014
6SodiumIBA
09/2021 - 01/2017
6Cyclin-Dependent Kinase Inhibitor p16IBA
03/2014 - 10/2009
6CytokinesIBA
01/2013 - 07/2008
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 04/2006
56- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
01/2022 - 10/2017
5Glucose (Dextrose)FDA LinkGeneric
09/2021 - 01/2017
5Metformin (Glucophage)FDA LinkGeneric
02/2021 - 10/2014
5Biological ProductsIBA
01/2020 - 04/2008
5ChemokinesIBA
02/2014 - 12/2010
5Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2013 - 04/2008
5Cadherins (E-Cadherin)IBA
05/2010 - 11/2007
4AntibodiesIBA
07/2021 - 01/2012
4LigandsIBA
06/2021 - 04/2006
4ipragliflozinIBA
02/2021 - 01/2016
4Immunoglobulins (Immunoglobulin)IBA
01/2021 - 07/2012
4CateninsIBA
09/2020 - 10/2009
4Pharmaceutical PreparationsIBA
01/2020 - 04/2016
4EnzymesIBA
10/2018 - 03/2009
4Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2010 - 07/2006
4NF-kappa B (NF-kB)IBA
02/2009 - 06/2007
3Estradiol (Delestrogen)FDA LinkGeneric
05/2022 - 12/2019
3Xanthine OxidaseIBA
01/2022 - 06/2016
3Sodium-Glucose Transport ProteinsIBA
01/2022 - 04/2017
3Rocuronium (Zemuron)FDA LinkGeneric
01/2022 - 11/2018
3Imatinib Mesylate (Gleevec)FDA Link
12/2021 - 12/2004
3pembrolizumabIBA
12/2021 - 03/2021
3Indicators and Reagents (Reagents)IBA
12/2021 - 08/2013
3Hemoglobins (Hemoglobin)IBA
12/2021 - 02/2021
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2021 - 01/2013
3Immune Checkpoint InhibitorsIBA
06/2021 - 10/2020
3Uric Acid (Urate)IBA
06/2021 - 06/2016
3Fetal Proteins (Fetoprotein)IBA
04/2021 - 11/2012
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 09/2014

Therapy/Procedure

22Therapeutics
01/2022 - 04/2006
14Radiotherapy
11/2021 - 12/2012
10Drug Therapy (Chemotherapy)
01/2022 - 10/2006
6Glycemic Control
02/2021 - 09/2014
3General Anesthesia
01/2022 - 01/2017
3Cholecystectomy
10/2021 - 09/2013
3Slit Lamp
03/2021 - 08/2020
3Transplantation
01/2021 - 01/2015